San Diego-based Agena Bioscience Inc. said that Peter Dansky has joined the company as its chief executive officer and as a member of the board of directors.
Dansky, former president of the molecular and cell biology division of Life Technologies, was also president of the functional analysis division at Applied Biosystems. He has 30 years of leadership experience in strategic business development, marketing, product development, sales, operations and general management from a variety of life science companies, including Arcturus Bioscience, Affymetrix, Molecular Dynamics, PerSeptive BioSystems and Millipore, Agena said.
He will lead Agena’s expansion of its genetic analysis business into new application areas including clinical diagnostics, the company said.
In May, it was announced that Agena had acquired Sequenom Inc.’s bioscience segment including a product called the MassArray System that includes lab equipment and chemicals for genotyping.
“Agena's powerful and efficient MassARRAY technology has gained worldwide adoption in the genetic research analysis arena and Peter’s experience in building life science companies will be invaluable as our company expands into new application areas,” said John Lillig, Agena’s chairman
“The company has the potential to become a leading research and diagnostics platform provider and its technology has excellent growth opportunities in many related life science application areas," Dansky said.